HER-2/neu splicing variant expression in human breast cancer: Comparison of RT-PCR and immunohistochemistry and fluorescence in situ hybridization

被引：0
|
作者：
Nazaka, H.
Kazama, R.
Kouga, H.
Muramatsu, A.
Arai, C.
Zheng, Z.
Miura, T.
Kasai, K.
Sato, T.
Okusawa, E.
Katayama, Y.
Uesugi, N.
Sugai, T.
Nakamura, S.
机构：
[1] Hirosaki Univ, Hirosaki, Aomori, Japan
[2] Hokkaido PWFAC Obihiro, Kosei Gen Hosp, Obihiro, Hokkaido, Japan
[3] City Hosp, Hachinohe, Aomori, Japan
[4] Iwate Med Univ, Morioka, Iwate 020, Japan
来源：
MODERN PATHOLOGY | 2008年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
206
引用
收藏
页码：47A / 47A
页数：1
相关论文
共 50 条
  • [21] Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis
    Lehr, HA
    Jacobs, TW
    Yaziji, H
    Schnitt, SJ
    Gown, AM
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2001, 115 (06) : 814 - 822
  • [22] HER-2 analysis in tissue microarrays of archival human breast cancer - Comparison of immunohistochemistry and fluorescence in situ hybridization
    O'Grady, A
    Flahavan, CM
    Kay, EW
    Barrett, HL
    Leader, MB
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2003, 11 (02): : 177 - 182
  • [23] HER-2/neu amplification and expression assessment: Comparison of immunohistochemistry, quantitative PCR and RT-PCR.
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 208 - 208
  • [24] HER-2/neu gene copy quantified by real-time PCR and serum HER-2/neu by Elisa assay: comparison with fluorescence in situ hybridization and immunohistochemistry
    Tse, C.
    Brault, D.
    Gligorov, J.
    Antoine, M.
    Lelay, K.
    Lotz, J. P.
    EJC SUPPLEMENTS, 2004, 2 (03): : 171 - 171
  • [25] Contribution of fluorescence in situ hybridization to immunohistochemistry for the evaluation of HER-2 in breast cancer
    Cianciulli, AM
    Botti, C
    Coletta, AM
    Buglioni, S
    Marzano, R
    Benevolo, M
    Cione, A
    Mottolese, M
    CANCER GENETICS AND CYTOGENETICS, 2002, 133 (01) : 66 - 71
  • [26] Chromogenic in situ hybridization for Her-2/neu-oncogene in breast cancer: comparison of a new dual-colour chromogenic in situ hybridization with immunohistochemistry and fluorescence in situ hybridization
    Mayr, Doris
    Heim, Sibylle
    Weyrauch, Kerstin
    Zeindl-Eberhart, Evelyn
    Kunz, Anne
    Engel, Jutta
    Kirchner, Thomas
    HISTOPATHOLOGY, 2009, 55 (06) : 716 - 723
  • [27] Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer:: A direct comparison of fluorescence in situ hybridization and immunohistochemistry
    Pauletti, G
    Dandekar, S
    Rong, HM
    Ramos, L
    Pong, HJ
    Seshadri, R
    Slamon, DJ
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) : 3651 - 3664
  • [28] Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer
    Sui, Weiguo
    Ou, Minglin
    Chen, Jiejing
    Wan, Youhua
    Peng, Hongbo
    Qi, Minfang
    Huang, He
    Dai, Yong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2009, 7 : 83
  • [29] Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in situ hybridization
    Shanmugalingam, Aswin
    Hitos, Kerry
    Pathmanathan, Nirmala
    Edirimmane, Senarath
    Hughes, T. Michael
    Ngui, Nicholas K.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 198 (01) : 143 - 148
  • [30] Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer
    Weiguo Sui
    Minglin Ou
    Jiejing Chen
    Youhua Wan
    Hongbo Peng
    Minfang Qi
    He Huang
    Yong Dai
    World Journal of Surgical Oncology, 7
12345